{"id":20881,"date":"2018-05-16T15:41:00","date_gmt":"2018-05-16T15:41:00","guid":{"rendered":"https:\/\/www.he-arc.ch\/projets-recherche\/diafev\/"},"modified":"2022-02-03T12:39:09","modified_gmt":"2022-02-03T11:39:09","slug":"diafev","status":"publish","type":"he-arc_project","link":"https:\/\/www.he-arc.ch\/en\/projets-recherche\/diafev\/","title":{"rendered":"DiaFev"},"content":{"rendered":"\n

Context and challenges<\/h2>\n\n\n\n

Bacterial resistance to antibiotics originating from misuse and overuse is becoming a major public health issue especially in developing countries. The cause of infection, whether bacterial or viral, is crucial to provide patients with the appropriate therapy and requires accurate determination.<\/p>\n\n\n\n

Objectives<\/h2>\n\n\n\n

Here, we want to address these needs through the development of a new type of quantitative multiplex tests based on lateral flow immunoassays by combining commercially available portative fluorescence readers with strips of paper modified for accurate quantification of biomarkers.<\/p>\n\n\n\n

Partners and funding<\/h2>\n\n\n\n

Institute of Life Technologies, HES-SO Valais<\/a><\/p>\n\n\n\n

COMATEC Institute, HEIG-VD<\/a><\/p>\n\n\n\n

Funded by the HES-SO<\/a><\/p>\n\n\n\n

Results<\/h2>\n\n\n\n

In the frame of the DiaFev project, we have developed:<\/p>\n\n\n\n